Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Not Confirmed
Not Confirmed
26-29 October, 2025
ISPE Annual MeetingISPE Annual Meeting
Not Confirmed
Not Confirmed
26-29 October, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS




Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Industry Trade Show
Not Confirmed
26-29 October, 2025
ISPE Annual MeetingISPE Annual Meeting
Industry Trade Show
Not Confirmed
26-29 October, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-re-expanding-our-cdmo-capabilities-to-meet-the-next-wave-of-complex-therapies-starting-with-oncology
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-chemexpress-invest-in-adc-facilities-cohance-to-set-up-oligonucleotide-facility-in-india

09 Dec 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/cytovia-therapeutics-presents-new-data-on-cd38-targeted-flex-nk-bispecific-antibody-at-2022-american-society-of-hematology-annual-meeting-301698987.html

09 Dec 2022
// BIONJ

07 Nov 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/cytovia-therapeutics-presents-new-data-on-talen-gene-edited-ink-cells-and-gpc3-targeted-flex-nk-bispecific-antibodies-at-2022-sitc-annual-meeting-301669887.html

27 Oct 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/cytovia-therapeutics-to-present-new-data-on-cd38-flex-nk-cell-engager-bispecific-antibodies-for-multiple-myeloma-at-2022-ash-annual-meeting-301661737.html

12 Sep 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/cytovia-therapeutics-presents-new-preclinical-data-for-its-gpc3-flex-nk-cell-engager-antibody-in-combination-with-natural-killer-cells-at-esmo-2022-in-paris-301621698.html

10 Jun 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/cytovia-therapeutics-presents-antitumor-activity-of-its-cd38-targeting-flex-nk-cell-engager-antibody-at-eha-2022-congress-301565565.html
ABOUT THIS PAGE